Advances in Treatment for Infectious Diseases 16th Lorne Infection and Immunity 2026

• Targeting Protective B Cell Epitopes for Prophylactic and Therapeutic Antibodies against Mpox     - Camila Coelho
• Orthology- and mutational constraint-guided drug repurposing efficiently identifies narrow-spectrum inhibitor of Mycobacterium tuberculosis acting through a new target - Eachan O Johnson
• RfxCas13d Enables Broad-Spectrum Suppression of Highly Pathogenic Avian Influenza - Sudip Dhakal
• New functions for γδ T cell-derived IL-4 in immunity to liver stage malaria - Lynette Beattie
• Using in vivo models to understand and target the drivers of inflammation and disease during severe acute SARS-CoV-2 infection and long COVID - Marcel Doerflinger

This session features a 2-minute talk from sponsor CSL.